Levonorgestrel and Ethinyl Estradiol NDC 79929-003

NDC codes

FDA NDC Directory

Product NDC (as listed)79929-003Labeler and product segments. Claims need a package NDC.

Product NDC at billing width79929-0003Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
79929-003-07	79929000307	3 BLISTER PACK in 1 CARTON (79929-003-07) / 1 KIT in 1 BLISTER PACKMarketed from Dec 31, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levonorgestrel and Ethinyl Estradiol
Generic name (nonproprietary): levonorgestrel and ethinyl estradiol
Dosage form: Kit
Labeler: Naari Pte Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207033
Marketing start: Dec 31, 2022
Listing expires: Dec 31, 2026
Identifiers: Product ID 79929-003_187b07d3-8d52-1dba-e063-6394a90aed64SPL ID 187b07d3-8d52-1dba-e063-6394a90aed64SPL set ID ea9f7216-0358-43a9-96eb-5dad694ae9b8RxCUI 238019, 748797, 748878

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N479929000307 followed by a unit qualifier and the quantity

Package 79929-0003-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 15, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Levonorgestrel and ethinyl estradiol tablets are indicated for use by females of reproductive potential to prevent pregnancy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)